IE
IMRX icon

Israel Englander’s Immuneering IMRX Stock Holding History

Israel Englander’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
330,402
-772,310
-70% -$3.91M ﹤0.01% 3965
2026
Q1 		$5.81M Buy
1,102,712
+1,051,789
+2,065% +$5.39M ﹤0.01% 2775
2025
Q4 		$335K Sell
50,923
-185,858
-78% -$1.19M ﹤0.01% 5193
2025
Q3 		$1.66M Buy
236,781
+174,532
+280% +$906K ﹤0.01% 4218
2025
Q2 		$210K Buy
62,249
+39,184
+170% +$67.2K ﹤0.01% 5341
2025
Q1 		$35.1K Sell
23,065
-79,871
-78% -$145K ﹤0.01% 5578
2024
Q4 		$226K Sell
102,936
-143,334
-58% -$297K ﹤0.01% 5233
2024
Q3 		$613K Sell
246,270
-706,956
-74% -$1.03M ﹤0.01% 4668
2024
Q2 		$1.22M Buy
953,226
+889,964
+1,407% +$1.46M ﹤0.01% 3960
2024
Q1 		$183K Buy
63,262
+51,824
+453% +$290K ﹤0.01% 5405
2023
Q4 		$84.1K Buy
+11,438
New +$76.2K ﹤0.01% 5382
2023
Q2 		– Sell
-98,786
Closed -$959K – 6378
2023
Q1 		$959K Buy
98,786
+79,116
+402% +$449K ﹤0.01% 4132
2022
Q4 		$95K Buy
19,670
+9,406
+92% +$83.3K ﹤0.01% 5597
2022
Q3 		$147K Sell
10,264
-118,389
-92% -$940K ﹤0.01% 5816
2022
Q2 		$696K Buy
128,653
+99,984
+349% +$533K ﹤0.01% 4697
2022
Q1 		$185K Sell
28,669
-1,087
-4% -$10.4K ﹤0.01% 5855
2021
Q4 		$481K Sell
29,756
-60,032
-67% -$1.46M ﹤0.01% 5084
2021
Q3 		$2.38M Buy
+89,788
New +$2.41M ﹤0.01% 3709

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Israel Englander's IMRX Position: Q2 2026 in Review

Israel Englander reduced its Immuneering (IMRX) stake by 70% in Q2 2026, selling an estimated $3.91M and leaving 330,402 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3965.

Israel Englander first reported a position in IMRX in Q3 2021 and has held it in 18 quarters since. The position peaked at $5.81M in Q1 2026. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Israel Englander held 330,402 shares of Immuneering worth $1.65M as of Q2 2026.
  • Israel Englander sold 772,310 Immuneering shares in Q2 2026, an estimated $3.91M.
  • Immuneering made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3965 holding.
  • Israel Englander first reported a position in Immuneering in Q3 2021 and has held it in 18 quarters since.
  • Israel Englander's Immuneering position peaked at $5.81M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.